共 50 条
- [1] Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mappingTRANSFUSION, 2022, 62 (11) : 2334 - 2348Chami, Btissam论文数: 0 引用数: 0 h-index: 0机构: Etab Francais Sang Ile France, Paris, France Etab Francais Sang Ile France, Paris, FranceOkuda, Makoto论文数: 0 引用数: 0 h-index: 0机构: Toho Univ, Med Ctr, Omori Hosp, Tokyo, Japan Etab Francais Sang Ile France, Paris, FranceMoayeri, Morvarid论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Transfus Serv, San Francisco, CA 94143 USA Etab Francais Sang Ile France, Paris, FrancePirenne, France论文数: 0 引用数: 0 h-index: 0机构: Etab Francais Sang Ile France, Paris, France Etab Francais Sang Ile France, Paris, FranceHidaka, Yoko论文数: 0 引用数: 0 h-index: 0机构: Toho Univ, Med Ctr, Omori Hosp, Tokyo, Japan Etab Francais Sang Ile France, Paris, FranceNambiar, Ashok论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Transfus Serv, San Francisco, CA 94143 USA Etab Francais Sang Ile France, Paris, FranceSong, Zhili论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceBedel, Olivier论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Sanofi, Amgen, Thousand Oaks, CA USA Etab Francais Sang Ile France, Paris, FranceZhang, Bailin论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceHopke, Joern论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Large Mol Res, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceDeng, Gejing论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceZhu, Chen论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceMace, Sandrine论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Res & Dev, Paris, France Etab Francais Sang Ile France, Paris, FranceChiron, Marielle论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Res & Dev, Paris, France Etab Francais Sang Ile France, Paris, FranceAdrian, Francisco论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Sanofi, HiFiBio Therapeut, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceFukao, Taro论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Etab Francais Sang Ile France, Paris, FranceBasile, Frank G.论文数: 0 引用数: 0 h-index: 0机构: Sanofi, Global Oncol, Cambridge, MA USA Sanofi, Nurix Therapeut, San Francisco, CA USA Etab Francais Sang Ile France, Paris, FranceMartin, Thomas论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Etab Francais Sang Ile France, Paris, France
- [2] The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple MyelomaCLINICAL CANCER RESEARCH, 2019, 25 (10) : 3176 - 3187Moreno, Laura论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainPerez, Cristina论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainZabaleta, Aintzane论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainManrique, Irene论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainAlignani, Diego论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainAjona, Daniel论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Inst Invest Sanitaria Navarra IDISNA, CIMA, Solid Tumors Program, CIBER ONC CB16 12 00443, Pamplona, Spain Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainBlanco, Laura论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainLasa, Marta论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainMaiso, Patricia论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainRodriguez, Idoia论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainGarate, Sonia论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainJelinek, Tomas论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain论文数: 引用数: h-index:机构:Moreno, Cristina论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainMerino, Juana论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainRodriguez-Otero, Paula论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainPanizo, Carlos论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainProsper, Felipe论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainSan-Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, SpainPaiva, Bruno论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain Clin Univ Navarra, CIMA, Inst Invest Sanitaria Navarra IDISNA, CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain
- [3] New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testingBLOOD TRANSFUSION, 2020, 18 (04) : 290 - 294Castro Izaguirre, Emma论文数: 0 引用数: 0 h-index: 0机构: Ctr Transfus Comunidad Valenciana, Valencia, Spain Ctr Transfus Comunidad Valenciana, Valencia, Spaindel Mar Luis-Hidalgo, Maria论文数: 0 引用数: 0 h-index: 0机构: Ctr Transfus Comunidad Valenciana, Valencia, Spain Ctr Transfus Comunidad Valenciana, Valencia, SpainLarrea Gonzalez, Luis论文数: 0 引用数: 0 h-index: 0机构: Ctr Transfus Comunidad Valenciana, Valencia, Spain Ctr Transfus Comunidad Valenciana, Valencia, SpainArbona Castano, Cristina论文数: 0 引用数: 0 h-index: 0机构: Ctr Transfus Comunidad Valenciana, Valencia, Spain Ctr Transfus Comunidad Valenciana, Valencia, Spain
- [4] Anti-CD38 interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.CANCER RESEARCH, 2021, 81 (13)Song, Zhili论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USABedel, Olivier论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAZhang, Bailin论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAHopke, Joern论文数: 0 引用数: 0 h-index: 0机构: Sanofi Large Mol Res, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USADeng, Gejing论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAMace, Sandrine论文数: 0 引用数: 0 h-index: 0机构: Sanofi Res & Dev, Paris, France Sanofi Global Oncol, Cambridge, MA USAChiron, Marielle论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAAdrian, Francisco论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAFukao, Taro论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USABasile, Frank论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USAPirenne, France论文数: 0 引用数: 0 h-index: 0机构: Etab Francais Sang Ile France, Paris, France Sanofi Global Oncol, Cambridge, MA USAOkuda, Makoto论文数: 0 引用数: 0 h-index: 0机构: Toho Univ, Med Ctr, Omori Hosp, Tokyo, Japan Sanofi Global Oncol, Cambridge, MA USAMoayeri, Morvarid论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Sanofi Global Oncol, Cambridge, MA USAChami, Btissam论文数: 0 引用数: 0 h-index: 0机构: Etab Francais Sang Ile France, Paris, France Sanofi Global Oncol, Cambridge, MA USAHidaka, Yoko论文数: 0 引用数: 0 h-index: 0机构: Toho Univ, Med Ctr, Omori Hosp, Tokyo, Japan Sanofi Global Oncol, Cambridge, MA USANambiar, Ashok论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Sanofi Global Oncol, Cambridge, MA USAMartin, Thomas论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Sanofi Global Oncol, Cambridge, MA USAZhu, Chen论文数: 0 引用数: 0 h-index: 0机构: Sanofi Global Oncol, Cambridge, MA USA Sanofi Global Oncol, Cambridge, MA USA
- [5] Dealing with anti-CD38 (daratumumab) interference in blood compatibility testingTRANSFUSION, 2016, 56 (03) : 778 - 779De Vooght, Karen M. K.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, NetherlandsOostendorp, Marlies论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlandsvan Solinge, Wouter W.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
- [6] A blockage monoclonal antibody protocol as an alternative strategy to avoid anti-CD38 interference in immunohematological testingTRANSFUSION, 2019, 59 (05) : 1827 - 1835Chinoca Ziza, Karen N.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilPaiva, Taina A.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilMota, Sabrina R.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilDezan, Marcia Regina论文数: 0 引用数: 0 h-index: 0机构: Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilSchmidt, Luciana Cayres论文数: 0 引用数: 0 h-index: 0机构: Fundacao Hemominas, Belo Horizonte, MG, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilBrunetta, Denise Menezes论文数: 0 引用数: 0 h-index: 0机构: HEMOCE Hematol & Hemotherapy Ctr, Fortaleza, Ceara, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilRicci, Gustavo论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilBasques, Fernando Valadares论文数: 0 引用数: 0 h-index: 0机构: Fundacao Hemominas, Belo Horizonte, MG, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilBarroso-Duarte, Fernando论文数: 0 引用数: 0 h-index: 0机构: HEMOCE Hematol & Hemotherapy Ctr, Fortaleza, Ceara, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilRocha, Vanderson论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil Univ Oxford, Churchill Hosp, NHSBT, Oxford, England Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilMendrone-Junior, Alfredo论文数: 0 引用数: 0 h-index: 0机构: Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, BrazilDinardo, Carla Luana论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil Univ Sao Paulo, Sch Med FMUSP, Discipline Hematol Transfus & Cell Therapy, Sao Paulo, Brazil
- [7] Critical Analysis on the Mechanism of Action (MoA) of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma (MM)BLOOD, 2016, 128 (22)Moreno, Laura论文数: 0 引用数: 0 h-index: 0Zabaleta, Aintzane论文数: 0 引用数: 0 h-index: 0Alignani, Diego论文数: 0 引用数: 0 h-index: 0Ajona, Daniel论文数: 0 引用数: 0 h-index: 0Lasa, Marta论文数: 0 引用数: 0 h-index: 0Maiso, Patricia论文数: 0 引用数: 0 h-index: 0Jelinek, Tomas论文数: 0 引用数: 0 h-index: 0Segura, Victor论文数: 0 引用数: 0 h-index: 0Delgado, Jose Antonio论文数: 0 引用数: 0 h-index: 0Rodriguez-Otero, Paula论文数: 0 引用数: 0 h-index: 0Prosper, Felipe论文数: 0 引用数: 0 h-index: 0San Miguel, Jesus论文数: 0 引用数: 0 h-index: 0Paiva, Bruno论文数: 0 引用数: 0 h-index: 0
- [8] Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML)BLOOD, 2017, 130Jelinek, Tomas论文数: 0 引用数: 0 h-index: 0Zabaleta, Aintzane论文数: 0 引用数: 0 h-index: 0Perez, Cristina论文数: 0 引用数: 0 h-index: 0Ajona, Daniel论文数: 0 引用数: 0 h-index: 0Alignani, Diego论文数: 0 引用数: 0 h-index: 0Rodriguez, Idoia论文数: 0 引用数: 0 h-index: 0Garate, Sonia论文数: 0 引用数: 0 h-index: 0Sarvide, Sarai论文数: 0 引用数: 0 h-index: 0Lasa, Marta论文数: 0 引用数: 0 h-index: 0Maiso, Patricia论文数: 0 引用数: 0 h-index: 0Prosper, Felipe论文数: 0 引用数: 0 h-index: 0Hajek, Roman论文数: 0 引用数: 0 h-index: 0San Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0Paiva, Bruno论文数: 0 引用数: 0 h-index: 0
- [9] MECHANISM OF ACTION (MOA) OF THE ANTI-CD38 MONOCLONAL ANTIBODY ISATUXIMAB IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)HAEMATOLOGICA, 2020, 105 : 60 - 60Zabaleta, Aintzane论文数: 0 引用数: 0 h-index: 0机构: CIMA IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, SpainJelinek, Tomas论文数: 0 引用数: 0 h-index: 0机构: Univ Ostrava, Fac Med Ostrava, Ostrava, Czech Republic CIMA IDISNA, Pamplona, SpainSimoes, Catia论文数: 0 引用数: 0 h-index: 0机构: CIMA IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, SpainPerez, Cristina论文数: 0 引用数: 0 h-index: 0机构: CIMA IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, SpainProsper, Felipe论文数: 0 引用数: 0 h-index: 0机构: CUN IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, SpainMartinez-Cuadron, D.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Fe, Valencia, Spain CIMA IDISNA, Pamplona, SpainBergua, J. M.论文数: 0 引用数: 0 h-index: 0机构: Hosp San Pedro de Alcantara, Caceres, Spain CIMA IDISNA, Pamplona, SpainVives, S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Barcelona, Spain CIMA IDISNA, Pamplona, SpainAlgarra, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Albacete, Albacete, Spain CIMA IDISNA, Pamplona, SpainTormo, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Valencia, Valencia, Spain CIMA IDISNA, Pamplona, SpainMartinez, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Madrid, Spain CIMA IDISNA, Pamplona, SpainSerrano, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Reina Sofia, Cordoba, Spain CIMA IDISNA, Pamplona, SpainHerrera, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Ramon & Cajal, Madrid, Spain CIMA IDISNA, Pamplona, SpainRamos, F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univt Leon, Leon, Spain CIMA IDISNA, Pamplona, SpainSalamero, O.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Vall dHebron, Barcelona, Spain CIMA IDISNA, Pamplona, SpainLavilla, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Lucus Augusti, Lugo, Spain CIMA IDISNA, Pamplona, SpainSanz, M. A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Fe, Valencia, Spain CIMA IDISNA, Pamplona, SpainMontesinos, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Fe, Valencia, Spain CIMA IDISNA, Pamplona, SpainSan Miguel, J. F.论文数: 0 引用数: 0 h-index: 0机构: CUN IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, SpainPaiva, Bruno论文数: 0 引用数: 0 h-index: 0机构: CIMA IDISNA, Pamplona, Spain CIMA IDISNA, Pamplona, Spain
- [10] Monoclonal Anti-CD38 and Anti-CD47 Therapy Interference with Platelet Antibody Screen Test MethodsTRANSFUSION, 2018, 58 : 51A - 51AVelliquette, Randall W.论文数: 0 引用数: 0 h-index: 0机构: New York Blood Ctr, New York, NY 10021 USA New York Blood Ctr, New York, NY 10021 USAKirkegaard, Julie论文数: 0 引用数: 0 h-index: 0机构: Community Blood Ctr Kansas City, Immunohematol Reference Lab, Kansas City, MO USA New York Blood Ctr, New York, NY 10021 USAJones, Daniel S.论文数: 0 引用数: 0 h-index: 0机构: Community Blood Ctr Kansas City, Immunohematol Reference Lab, Kansas City, MO USA New York Blood Ctr, New York, NY 10021 USAWinkhart, Kelly论文数: 0 引用数: 0 h-index: 0机构: Community Blood Ctr Kansas City, Immunohematol Reference Lab, Kansas City, MO USA New York Blood Ctr, New York, NY 10021 USALomas-Francis, Christine论文数: 0 引用数: 0 h-index: 0机构: New York Blood Ctr, New York, NY 10021 USA New York Blood Ctr, New York, NY 10021 USAWesthoff, Connie M.论文数: 0 引用数: 0 h-index: 0机构: New York Blood Ctr, New York, NY 10021 USA New York Blood Ctr, New York, NY 10021 USA